The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis

CONCLUSION: The use of chidamide in conjunction with BV may positively affect and enhance T-cellular apoptotic pathways without offsetting each other.PMID:37921901 | DOI:10.1007/s00280-023-04609-5
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research